Skip to Content

WATSON 761 (Ranitidine 300 mg)

Pill imprint WATSON 761 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; eczema; gastric ulcer maintenance treatment (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 300 mg WATSON 761
Discount Card Promo
Ranitidine hydrochloride
Imprint:
WATSON 761
Strength:
300 mg
Color:
Beige
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0761
Inactive Ingredients:
silicon dioxide colloidal
hypromellose
magnesium stearate
maltodextrin
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium bicarbonate
synthetic ferric oxide red
synthetic ferric oxide yellow
magnesium silicate
titanium dioxide
triethyl citrate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide